“Rare” uterine sarcoma not rare at all
Power morcellators are devices used to remove non-cancerous uterine fibroids by breaking up the growths into pieces before retrieving it out of the body. Many gynecologists previously recommended the use of a power morcellator when treating uterine growths, despite the fact that uterine sarcoma could be hidden in these presumed benign fibroids.
Uterine sarcomas are cancer cells that develop in the muscles of the uterus or the tissues that support it. Although many assume uterine sarcoma as a rare occurrence, several studies have found that it is not as rare as it is believed to be. In fact, a 1990 study at a hospital in Los Angeles revealed that around 1 in 200 women who underwent uterine fibroid surgeries had hidden sarcoma. The results were later supported by two studies done in 1999 and 2008, which revealed ratios of one-in-462 and one-in-253, respectively.
Undergoing uterine fibroid surgery with a power morcellator can spread uterine sarcoma, thereby exacerbating the condition. At Williams Kherkher, we help power morcellator victims seek compensation from the manufacturers involved. Call us at (800) 220-9341 today.